Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Items 401–500 of 531
Toxoplasma gondii DNA methyltransferases regulate parasitic energy metabolism
Chen, M., Zhou, L., Li, S., Wei, H., Chen, J., Yang, P., & Peng, H. (2022) · Acta Tropica · doi:10.1016/j.actatropica.2022.106329 · Cited by 3
Dinda, B., & Saha, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92196-5_1 · Cited by 2
Epigenetics of Metabolic Diseases
Gillberg, L., & Hjort, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00026-8 · Cited by 2
Lysenkov, S. P., TKHAKUSHINOV, R. A., Muzhenya, D. V., & Рамазановна, Т. А. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.02.003 · Cited by 2
Epigenetics of Diabetes in Humans
Nano, J., Portilla-Fernández, E., Troup, J., Ghanbari, M., Franco, O. H., & Muka, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00016-9 · Cited by 3
Morais-Junior, G. S., Souza, V. C., Machado‐Silva, W., Henriques, A. D., Avelar, G. G., Pérez, D. I. V., Lima, R. M., Silva, R. J. D. S., Brito, C. J., & Nóbrega, O. D. T. (2019) · NeuroImmunoModulation · doi:10.1159/000502746 · Cited by 2
Epigenetic Epidemiology of Obesity and Type 2 Diabetes
Ling, C., Ruhrmann, S., Säll, J., Bacos, K., & Rönn, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-94475-9_19 · Cited by 2
Self-citationEpigenetic Signature of Impaired Fasting Glucose in the Old Order Amish
Montasser, M. E., Cheng, Y. C., Tanner, K., Shuldiner, A. R., & Connell, J. R. O. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100052 · Cited by 1
Type 1 Diabetes in 2023 - From Real Practice to Open Questions
Chlup, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100991 · Cited by 1
The role of several SNPs in genetic diagnosis of Type 2 diabetes mellitus
Akhundova, L., Mustafayev, N., & Huseynova, I. M. (2023) · INSTITUTE OF MOLECULAR BIOLOGY & BIOTECHNOLOGIES TRANSACTIONS · doi:10.62088/timbb/7.2.3 · Cited by 1
Raj, N., Karmakar, A., Narayan, G., & Thummer, R. P. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_859 · Cited by 1
Shi, X., Song, H., Xiong, X., Wei, S., Zhang, L., You, S., Zhou, W., Ji, G., Liu, B., & Wu, N. (2026) · Clinical Epigenetics · doi:10.1186/s13148-025-01950-9 · Cited by 1
“It has been reported that SNPs of KCNQ1 were highly related to obesity, T2DM, MASH, and HCC [18, 26, 27], and differential DNA methylation of KCNQ1 was observed in T2DM [28] and HCC patients [22].”
The role of genetic and epigenetic factors in developing polycystic ovary syndrome
Koval, Y. E., Дмитриевна, К. Т., Игнатко, И. В., Bakhtiyarov, K. R., Gilmutdinova, I., & Владимировна, В. Е. (2026) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2026.766 · Cited by 1
Yang, M., Wang, M., Zhao, X., Xu, F., Liang, S., Wang, Y., Wang, N., Sambou, M. L., Jiang, Y., & Dai, J. (2024) · Epigenomics · doi:10.2217/epi-2023-0343 · Cited by 2
Shin, J., Bressler, J., Grove, M. L., Brown, M. R., Selvin, E., Pankow, J. S., Fornage, M., Morrison, A. C., & Sarnowski, C. (2025) · Epigenetics · doi:10.1080/15592294.2025.2498857 · Cited by 2
“This gene has been found to be differentially methylated in pancreatic islets of individuals with type 2 diabetes [48] (Table S14).”
Alami, H. E., Bouqdayr, M., Errafii, K., Messaoudi, N., Sehli, S., Idrissi, N. A., Abidi, O., Rhalem, W., Khlil, N., Ghazal, H., et al. (2025) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2025.2532089 · Cited by 1
“[25] Although many studies have investigated the role of the C677T polymorphism of MTHFR gene in various populations worldwide, their findings remain inconclusive.”
Rezaei, S. A. S., Amirfiroozy, A., Kohkalani, M., & Mehri, M. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998443779260129064444 · Cited by 4
Epigenetic age acceleration in diabetes and its clinical implications
Khan, W. A., & Gupta, J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113254 · Cited by 1
Zhou, Y., Yang, R., Wang, Q., Li, J., Yang, Y., Shi, Y., & Liu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1810613 · Cited by 5
“Epigenetic regulation, including DNA methylation and histone modification plays key roles in the development of T2DM (204, 205).”
PARylation, DNA (De)methylation, and Diabetes
Vidaković, M., Tolić, A., Grdović, N., Ravichandran, M., & Jurkowski, T. P. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_55 · Cited by 1
Mechanisms of Programming: Pancreatic Islets and Fetal Programming
Barella, L. F., Mathias, P. C. D. F., & de Oliveira, J. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-60289-9_37 · Cited by 2
Bariatric Surgery Induces Hypomethylation of Genes Related to Type 2 Diabetes and Insulin Resistance
Vohl, M. (2017) · International Journal of Molecular Biology Open Access · doi:10.15406/ijmboa.2017.02.00020 · Cited by 2
“[10] showed that the epigenetic signature of pancreatic islets of T2D-patients was significantly different to that of islets from healthy donors, mainly at genes involved in insulin secretion and glucose homeostasis [10,11].”
Schimpf, A. R. A., Formichela, M. M., Mascheroni, M. B., Rivero, D., Chamorro, M. L., Portillo, V., Zapata, P. D., & Ferri, C. A. (2022) · Revista de Ciencia y Tecnología · doi:10.36995/j.recyt.2022.37.009 · Cited by 2
Molecular Challenges and Advances in Clinical Islet Transplantation
Mohan, N., & Sunder, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108571 · Cited by 2
The role of genetic and epigenetic factors in familial clustering of metabolic syndrome
Yousuf, S. D., & Ganie, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00051-7 · Cited by 1
Wal, P., Kumar, P., Bhardwaj, H., Sharma, K., Tripathi, A. K., Gupta, A., Wal, A., & Sharma, M. C. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998288090240509105717 · Cited by 3
Smail, H. O. (2024) · Science Journal of University of Zakho · doi:10.25271/sjuoz.2024.12.2.1259 · Cited by 1
“By further investigating the genome-wide methylation patterns in the pancreatic islets of diabetic patients, these findings enhance our understanding of the role DNA methylation plays in the pathophysiology of type 2 diabetes (Dayeh et al., 2014 ; Mutize et al., 2018).”
Investigation of KLF14 Promoter Methylation in Patients with Type 2 Diabetes. A Preliminary Analysis
Alvarez, M. F., Fernandez, G. A., Elfrida, S. S., & Gómez, M. E. V. (2024) · OALib · doi:10.4236/oalib.1111888 · Cited by 1
Gene Expression Modifications in Type 2 Diabetes
Suárez‐Sánchez, F., & Gómez-Zamudio, J. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_10 · Cited by 1
Oduaran, O. H. (2015) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
The association of DNA methylation patterns in TCF7L2 and GIPR genes with Type 2 Diabetes
Canivell, S. (2014) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 3
Novel Roles of p21 in Apoptosis During Beta-Cell Stress in Diabetes
Hernandez, A. M. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2008 · Cited by 1
Epigenetics, the Vascular Wall, and Atherosclerosis
Lund, G., & Zaina, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65409-0 · Cited by 1
DNA methylation in type 2 diabetes and metabolic health
Walaszczyk, E. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.180629925 · Cited by 1
Curcumin and Analogues as Potential Epigenetic Modulators: Prevention of Metabolic DiseasesPreprint
Tang, C., Liu, Y., Liu, S., Yang, C., Chen, L., Fengru, T. A. N. G., Wang, F., Zan, L., Deng, H., Lin, Y., et al. (2024) · doi:10.22541/au.170666150.09141621/v1 · Cited by 1
Type-2 diabetes biomarker discovery and risk assessment through saliva DNA methylomePreprint
Guo, W., Morselli, M., Paul, K. C., Thompson, M. J., Ritz, B. R., & Pellegrini, M. A. (2024) · medRxiv · doi:10.1101/2024.12.20.24319403 · Cited by 2
Cai, W., Song, Q., Mo, X., Li, H., Song, Y., & Yin, L. (2025) · eLife · doi:10.7554/elife.104550.1 · Cited by 3
The Time has Come (and the Tools are Available) for Nutriepigenomics Studies
Yan, P. S. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch33
Genome-Wide DNA and Histone Modification Studies in Metabolic Disease
Ling, C., & Rönn, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800140-0.00012-1
Self-citationMaretty, L., Sibbesen, J. A., & Krogh, A. (2014)
Complications of diabetes: an unsolicited epigenetic memory
Gurusamy, N., Sukumaran, V., Alhazzani, A. A., Shatoor, A. S., Watanabe, K., & Shirai, M. (2015) · Diabesity · doi:10.15562/diabesity.2015.6
Epigenetics in Type 2 Diabetes
Ling, C., & Pasquali, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_11 · Cited by 1
Self-citationEpigenetic Regulation of Islet Development and Regeneration
Khare, S., Katre, P. A., & Galande, S. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-45307-1_4
Discovery of problematic probes in illumina DNA methylation microarrays
Chen, Y. A. (2015) · TSpace (University of Toronto)
DNA methylation : a risk factor for type 2 diabetes mellitus
Mutize, T. (2016) · Cited by 1
Genomics and Epigenomics of Common Human Metabolic and Heart Disease
Multhaup, M. (2015)
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_6-1
TET2: Is a potential gatekeeper for the action of thiazolidinedione in fat cells?
Seo, J. A., & Kim, Y. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.001
Locus specific DNA methylation in human immunological responses
Bergman, E. A. (2018) · Figshare
Long-term Impacts of Early Life Antibiotic Exposure on Intestinal Microbiota and Metabolic Disease
Li, J. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rv0db74
Epigenomics of Diabetes Mellitus
Dimova, I. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814513-5.00012-x
Paul, S., & Bansal, S. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621342
“This might sometime result in inconsistent reports about the genes and the genetic pathway responsible for diabetes [7] [8] [9].”
Pharmacoepigenetics in Type 2 Diabetes Mellitus
DiStefano, J. K., & Watanabe, R. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00018-8
Mutize, T., Dludla, P. V., Mkandla, Z., & Nkambule, B. B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/825125
“Previous studies have shown that differential methylation in adipose tissues, muscles and pancreatic islets are associated with localised inflammation in patients with T2DM (Kulkarni et al., 2012; Yang et al., 2012; Ribel-Madsen et al., 2012; Nilsson et al., 2014; Dayeh et al., 2014).”
InfluentialEpigenetics and Chronic Inflammation: Role in Early Detection of Type 2 Diabetes
Ghai, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_18
Therapeutic Epigenetics- A Boon to the Future
Dhas, D. B. B. (2016) · Annals of SBV · doi:10.5005/jp-journals-10085-5106
Roy, A. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20210250
“Functional analysis of both β and α cell revealed different results such as, exocytosis during insulin secretion reduced due to the silencing of the Exoc3L gene; insulin secretion impaired when Cdkn1a, Pde7b are overexpressed in β cell, and also hampered β cell proliferation.(20)”
Other omics approaches to the study of rare diseases
Gatta, G. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820140-4.00008-9
Twin and family epigenetic studies of type 2 diabetes
Christiansen, C., Potier, L., & Bell, J. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820951-6.00005-3
PARylation, DNA (De)methylation, and Diabetes
Vidaković, M., Tolić, A., Grdović, N., Ravichandran, M., & Jurkowski, T. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_55-2
PARylation, DNA (De)methylation, and Diabetes
Vidaković, M., Tolić, A., Grdović, N., Ravichandran, M., & Jurkowski, T. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_55-1
اكتشاف جين جديد يساهم في الإصابة بمرض السكري ويؤثر في استقلاب الغلوكوز
تنيرة, ج., الرفاعي, ل., & محمد, ع. ا. (2022) · Arabian Journal of Scientific Research-المجلة العربية للبحث العلمي · doi:10.5339/ajsr.2022.2
Improving the personalized prediction of complex traits and diseases: application to type 2 diabetes
Pärna, K. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.230450750
Epigenomics of Type 2 Diabetes
Parveen, A. N., & Dhawan, B. S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00053
Epigenetic mechanisms in cardiovascular diseases
Varadarajan, S., Ushio‐Fukai, M., & Fukai, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00020-7
Methylation of nonessential genes in cutaneous melanoma – Rule Out hypothesis
Gorlov, I., Conway, K., Edmiston, S. N., Parrish, E., Hao, H., Amos, C. I., Tsavachidis, S., Gorlova, O. Y., Begg, C. B., Hernando, E., et al. (2023) · Melanoma Research · doi:10.1097/cmr.0000000000000881
Gene Expression Modifications in Type 2 Diabetes
Suárez‐Sánchez, F., & Gómez-Zamudio, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_11
Correlation of ChREBP Gene Methylation with Pathological Characteristics of Type 2 Diabetes Mellitus
Wang, X., Huangfu, W., & Zhao, F. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04714-4
“Another study also exhibited 102 of the differentially methylated genes, including cyclin-dependent kinase inhibitor 1 A (CDKN1A), phosphodiesterase 7B (PDE7B), septin 9 (SEPT9), and exocyst complex component 3 like 2 (EXOC3L2), were differentially expressed in T2DM patients [13].”
The Part Breast Milk Plays in Epigenetic Programming
Şahin, Ö. N. (2023) · Springer eBooks · doi:10.1007/978-3-031-33278-4_12 · Cited by 2
A New Gene Contributes to Diabetes and Affects Glucose Metabolism
(2023) · International Journal of Clinical & Experimental Dermatology · doi:10.33140/ijced.08.02.06
Yousri, N. A., Albagha, O., & Hunt, S. C. (2023) · Figshare · doi:10.6084/m9.figshare.24104315
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24819507
Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics
Giovanni, T., Giannese, F., & Lazarević, D. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_131-1
Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics
Tonon, G., Giannese, F., & Lazarević, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_131
Cai, W., Song, Q., Mo, X., Li, H., Song, Y., & Yin, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.01.621468
“Changes in DNA methylation patterns related to β cell function (Dayeh et al., 2014) and identity have been shown in islet of diabetic patients and have been shown to affect β cell senescence and functional maturation (Avrahami et al., 2015; Golson & Kaestner, 2017), but little is known about the…”
Terzi, M. Y., Küçük, M. U., Yılmaz, M. Ö., & Kaya, Z. İ. (2024) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1523669
Ahrtz, L. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/175148
Cai, W., Song, Q., Mo, X., Li, H., Song, Y., & Yin, L. (2025) · eLife · doi:10.7554/elife.104550
Epigenetic modifications of metabolic diseases
Mekhova, L. (2025) · doi:10.71012/pro-ageing-2025-1-05
Islet-specific DNA hypomethylation identifies gene enhancer loci driving Type 2 Diabetes riskPreprint
Miranda, V. E., Scott, T. J., Dorans, E., Mei, S., Miranda, A. X., Powers, A. C., Davis, L. K., Briššová, M., & Hodges, E. C. (2025) · medRxiv · doi:10.1101/2025.09.09.25335336
Discovery and performance of DNA methylation panels for cancer detection and classification in bloodPreprint
Margolin, G., Bang-Christensen, S. R., Grimm, S. A., Bennett, B. D., Kilfeather, P., Fedkenheuer, K., Pathan, S., Whitlock, N. C., Pinto, P. A., Klimczak, L. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676542
“Additionally, we used tissue and peripheral blood cell DNA from several non-cancer conditions, whose methylation array data served as negative controls (GSE32148, GSE85566, GSE50874, GSE49542, and GSE87621), as well as Dayeh et al. (2014) [35] (summarized in Table 3).”
Akhtar, M. T., Karajgar, M. D., Mahajan, Y. V., Shah, M. M., Ghule, V. R., Takale, D. G., Mahalle, P. N., & Sule, B. (2025) · Lecture notes in networks and systems · doi:10.1007/978-981-96-7517-3_1
Epigenetics, the vascular wall and atherosclerosis
Lund, G., & Zaina, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00302-2
Varghese, S. S., Peña, A. G. H.-D. L., Pandey, A., Anchondo, L. M., Wu, X., Bhattacharya, S., & Dhawan, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.10.687707
Tan, Y., Peng, H., Wang, S., Hu, P., Zheng, Y., Zhang, H., Guo, H., Li, Y., Zhang, H., Wu, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1705584
Genes, Environment, and Epigenetics in Neural Tube Defects
Krupp, D. R. (2014) · DukeSpace (Duke University)
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649537
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649504
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649543
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649501
Additional file 1 of DNA methylation and type 2 diabetes: a systematic review
Nadiger, N., Veed, J. K., Chinya Nataraj, P., & Mukhopadhyay, A. (2024) · Figshare · doi:10.6084/m9.figshare.25844447
Additional file 2 of DNA methylation and type 2 diabetes: a systematic review
Nadiger, N., Veed, J. K., Chinya Nataraj, P., & Mukhopadhyay, A. (2024) · Figshare · doi:10.6084/m9.figshare.25844547
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649534
Burton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633514
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649498
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649540
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649492
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654428
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.